Sign in to view content

Impact of Intravitreal Anti-VEGF Therapy for Severe Non-Proliferative Diabetic Retinopathy (NPDR): Analyses Through a Monte-Carlo Simulation Model

Andrew A. Moshfeghi, MD, MBA, FASRS

Video
Published 2021

Related

Long-term Anti-VEGF Treatment Following Vitrectomy for Endophthalmitis in Patients With Neovascular AMD
Zofia Anna Nawrocka (vel Michalewska), MD, PhD
Annual Meeting Talks
2018
Plasma Arginine and Citrulline are Elevated in Diabetic Retinopathy
Milam A. Brantley, MD, PhD
On Demand Cases, Courses, and Papers
2019
Diabetic Retinopathy Progression in Anti-VEGF Versus Fluocinolone Acetonide Implant Treated Eyes Who Are Lost to Follow-up
Caesar K. Luo, MD, FASRS
Annual Meeting Talks
2020

Category: Diabetic Retinopathy

See more